Zong‐Tao Chai

2.6k total citations
68 papers, 2.0k citations indexed

About

Zong‐Tao Chai is a scholar working on Molecular Biology, Hepatology and Cancer Research. According to data from OpenAlex, Zong‐Tao Chai has authored 68 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 25 papers in Hepatology and 18 papers in Cancer Research. Recurrent topics in Zong‐Tao Chai's work include Hepatocellular Carcinoma Treatment and Prognosis (24 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers) and Liver Disease and Transplantation (8 papers). Zong‐Tao Chai is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (24 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers) and Liver Disease and Transplantation (8 papers). Zong‐Tao Chai collaborates with scholars based in China, Hong Kong and Australia. Zong‐Tao Chai's co-authors include Hui‐Chuan Sun, Xiao‐Dong Zhu, Shuqun Cheng, Jian‐Yang Ao, Zhao–You Tang, Xiuping Zhang, Zhenhua Chen, De-Ning Ma, Jie Shi and Wei‐Xing Guo and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Zong‐Tao Chai

65 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zong‐Tao Chai China	25	898	605	545	398	276	68	2.0k
Rongxin Chen China	29	802 0.9×	781 1.3×	592 1.1×	760 1.9×	357 1.3×	114	2.5k
Stefano Caruso France	28	969 1.1×	391 0.6×	687 1.3×	471 1.2×	237 0.9×	55	1.9k
Victoria Tovar Spain	19	1.1k 1.2×	534 0.9×	639 1.2×	456 1.1×	378 1.4×	26	2.3k
Francesco Dituri Italy	23	1.4k 1.6×	474 0.8×	692 1.3×	788 2.0×	337 1.2×	62	2.5k
Bazarragchaa Damdinsuren Japan	28	858 1.0×	563 0.9×	485 0.9×	802 2.0×	705 2.6×	42	2.3k
Shuang‐Jian Qiu China	21	1.4k 1.5×	378 0.6×	1.2k 2.3×	428 1.1×	224 0.8×	36	2.3k
Kaoru Mogushi Japan	29	1.6k 1.8×	312 0.5×	799 1.5×	756 1.9×	203 0.7×	93	2.7k
Chris K. Sun Hong Kong	23	791 0.9×	333 0.6×	316 0.6×	299 0.8×	152 0.6×	25	1.4k
Le‐Qun Li China	20	685 0.8×	312 0.5×	598 1.1×	542 1.4×	246 0.9×	63	1.5k
Silvia Ribback Germany	26	1.3k 1.5×	350 0.6×	782 1.4×	461 1.2×	137 0.5×	84	2.5k

Countries citing papers authored by Zong‐Tao Chai

Since Specialization

Citations

This map shows the geographic impact of Zong‐Tao Chai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zong‐Tao Chai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zong‐Tao Chai more than expected).

Fields of papers citing papers by Zong‐Tao Chai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zong‐Tao Chai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zong‐Tao Chai. The network helps show where Zong‐Tao Chai may publish in the future.

Co-authorship network of co-authors of Zong‐Tao Chai

This figure shows the co-authorship network connecting the top 25 collaborators of Zong‐Tao Chai. A scholar is included among the top collaborators of Zong‐Tao Chai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zong‐Tao Chai. Zong‐Tao Chai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wei, Jiacheng, Xun Lu, Jianxiang Huang, et al.. (2025). In silico identification and experimental validation of long-range allosteric inhibition of Staphylococcus aureus Cas9 catalytic activity by an anti-CRISPR protein AcrIIA14. International Journal of Biological Macromolecules. 310(Pt 2). 143324–143324. 6 indexed citations

Wang, Chen, Cai Chen, Zong‐Tao Chai, et al.. (2025). AURKB as a Therapeutic Target and Key Driver of Liver Cancer Growth and Metastasis. Apmis. 133(4). e70021–e70021.

Gao, Qi, et al.. (2025). Comparison of clinical efficacy of unilateral biportal endoscopic discectomy and percutaneous endoscopic interlaminar discectomy in the treatment of lumbar disc herniation at different segments. European Spine Journal. 34(12). 5799–5810.

Wang, Chen, et al.. (2025). NAT10‐Mediated N4‐Acetylation of SLC7A11 mRNA Promotes Hepatocellular Carcinoma Progression and Metastasis by Repressing Ferroptosis. Journal of Biochemical and Molecular Toxicology. 39(9). e70496–e70496.

Lu, Shaoyong, Xinheng He, Zhao Yang, et al.. (2021). Activation pathway of a G protein-coupled receptor uncovers conformational intermediates as targets for allosteric drug design. Nature Communications. 12(1). 4721–4721. 160 indexed citations

Chen, Zhenhua, Xiuping Zhang, Shuang Feng, et al.. (2021). Liver resection versus intensity-modulated radiation therapy for treatment of hepatocellular carcinoma with hepatic vein tumor thrombus: a propensity score matching analysis. HepatoBiliary Surgery and Nutrition. 10(5). 646–660. 9 indexed citations

Zhang, Xiuping, Tengfei Zhou, Ziyang Sun, et al.. (2021). Association of Preoperative Coagulability With Incidence and Extent of Portal Vein Tumor Thrombus and Survival Outcomes in Hepatocellular Carcinoma After Hepatectomy: A Large-Scale, Multicenter Study. Frontiers in Oncology. 11. 697073–697073. 3 indexed citations

Chen, Zhenhua, Kang Wang, Xiuping Zhang, et al.. (2020). A new classification for hepatocellular carcinoma with hepatic vein tumor thrombus. HepatoBiliary Surgery and Nutrition. 9(6). 717–728. 14 indexed citations

Ma, De-Ning, et al.. (2020). Hypoxia-induced downregulation of B-cell translocation gene 3 confers resistance to radiation therapy of colorectal cancer. Journal of Cancer Research and Clinical Oncology. 146(10). 2509–2517. 4 indexed citations

10.

Zhang, Fan, Chong‐De Lu, Xiuping Zhang, et al.. (2019). The impact of portal vein tumor thrombus on long-term survival after liver resection for primary hepatic malignancy. HPB. 22(7). 1025–1033. 9 indexed citations

11.

Zhang, Xiuping, Zong‐Tao Chai, Yuzhen Gao, et al.. (2019). Postoperative adjuvant sorafenib improves survival outcomes in hepatocellular carcinoma patients with microvascular invasion after R0 liver resection: a propensity score matching analysis. HPB. 21(12). 1687–1696. 60 indexed citations

12.

Sun, Juxian, Jie Shi, Chang Liu, et al.. (2019). Postoperative adjuvant IMRT for patients with HCC and portal vein tumor thrombus: An open-label randomized controlled trial. Radiotherapy and Oncology. 140. 20–25. 37 indexed citations

13.

Chen, Zhenhua, Xiuping Zhang, Hang Wang, et al.. (2019). Effect of microvascular invasion on the postoperative long-term prognosis of solitary small HCC: a systematic review and meta-analysis. HPB. 21(8). 935–944. 62 indexed citations

14.

Chen, Zhenhua, Xiuping Zhang, Tengfei Zhou, et al.. (2019). Adjuvant transarterial chemoembolization improves survival outcomes in hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis. European Journal of Surgical Oncology. 45(11). 2188–2196. 57 indexed citations

15.

Zhang, Xiuping, Zhenhua Chen, Juxian Sun, et al.. (2019). Postoperative Adjuvant Transarterial Chemoembolization Improves Outcomes of Hepatocellular Carcinoma Associated with Hepatic Vein Invasion: A Propensity Score Matching Analysis. Annals of Surgical Oncology. 26(5). 1465–1473. 35 indexed citations

16.

Qin, Chengdong, De-Ning Ma, Shi-Zhe Zhang, et al.. (2018). The Rho GTPase Rnd1 inhibits epithelial–mesenchymal transition in hepatocellular carcinoma and is a favorable anti-metastasis target. Cell Death and Disease. 9(5). 486–486. 21 indexed citations

17.

Ao, Jian‐Yang, Xiao‐Dong Zhu, Zong‐Tao Chai, et al.. (2017). Colony-Stimulating Factor 1 Receptor Blockade Inhibits Tumor Growth by Altering the Polarization of Tumor-Associated Macrophages in Hepatocellular Carcinoma. Molecular Cancer Therapeutics. 16(8). 1544–1554. 153 indexed citations

18.

Zhao, Yiming, Hongwei He, Zong‐Tao Chai, et al.. (2012). Clinical Experience with Primary Hepatic Epithelioid Hemangioendothelioma: Retrospective Study of 33 Patients. World Journal of Surgery. 36(11). 2677–2683. 37 indexed citations

19.

Wang, Wenquan, Hui‐Chuan Sun, Huaxiang Xu, et al.. (2012). Tanshinone IIA inhibits metastasis after palliative resection of hepatocellular carcinoma and prolongs survival in part via vascular normalization. Journal of Hematology & Oncology. 5(1). 69–69. 50 indexed citations

20.

Wang, Wenquan, Hui‐Chuan Sun, Liang Liu, et al.. (2010). A novel tripeptide, tyroserleutide, inhibits irradiation-induced invasiveness and metastasis of hepatocellular carcinoma in nude mice. Investigational New Drugs. 29(5). 861–872. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact